A mutant form of a meek microbe deals a gutsy blow to colon cancer, University of Florida scientists have discovered. The special bacteria halted abnormal inflammation, reduced precancerous growths and reversed progression of severe cancerous lesions in the large intestines of mice. The findings appear June 11 in the Proceedings of the National Academy of Sciences.
Recent PostsSaturday, January 14, 2017
The University of South Florida College of Engineering and the USF Health Morsani College of Medicine have established the Department of Medical Engineering, a unique transdisciplinary concept that will combine the related aspects of engineering and medicine while providing access to real-world health care environments for education and research. ..Read More ⇒Thursday, January 12, 2017
Florida-based Flight Level Engineering has become the first company to join the Customized Business Acceleration Program at the John Mica Engineering and Aerospace Innovation Complex (MicaPlex) at Embry-Riddle Research Park in Daytona Beach. ..Read More ⇒Thursday, January 12, 2017
According to a 2015 report by the NIH’s National Institute on Aging, in the last five years of life, total health care spending for people with dementia was more than a quarter of a million dollars per person, 57 percent more than the costs associated with death from other diseases, including cancer and heart disease. ..Read More ⇒Thursday, January 12, 2017
Immunotherapy is a fast growing area of cancer research. It involves developing therapies that use a patient’s own immune system to fight and kill cancer. Moffitt Cancer Center is working on a new vaccine that would help early-stage breast cancer patients who have HER2 positive disease. ..Read More ⇒Wednesday, January 11, 2017
Graft-versus-host-disease (GVHD) is the leading cause of non-relapse associated death in patients who receive stem cell transplants. In a new study published as the cover story in Science Translational Medicine, Moffitt Cancer Center researchers show that a novel treatment can effectively inhibit the development of GVHD in mice and maintain the infection- and tumor-fighting capabilities of the immune system. ..Read More ⇒
Tagsinnovation Scripps Research Institute grants Univeristy of South Florida IHMC astronomy physics AGTC awards aerospace FL Institute for Commercialization of Public Research University of North Florida children HIV/AIDS Moffitt Cancer Center BioFlorida energy sciences research policy Florida Power & Light health care biotechnology magnets technology marine consumers cancer University of West Florida animals environment materials science Max Planck sustainability clean energy University of Central Florida bioscience green technology VGTI stem cell education Florida State University computer science neuroscience Nova Southeastern Univ. economy health Florida Institute of Technology business ICFO University of Florida Florida Gulf Coast Univ. Florida Hospital Jackson Lab FAMU biochemistry photonics policy University of Miami Florida Atlantic University Mayo Clinic accounting medical Sanford-Burnham commercialization Nanotheraputics Torrey Pines Institute society/culture Florida Trend Draper Embry-Riddle gender agriculture aging AxoGen research Banyan Biomarkers accreditation nanotechnology biomedical robotics ecology partnerships Enterprise Florida conference / event engineering accolades Florida International Univ. GrowFL